{
    "2021-10-21": [
        [
            {
                "time": "",
                "original_text": "甘李药业：股东明华创新、宽街博华拟分别减持不超过1%股份 拟减持股份",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "明华创新",
                        "宽街博华",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "甘李药业：股东拟合计减持不超2%公司股份 拟减持股份",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "股东",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "甘李药业(603087.SH)股东明华创新等拟减持不超1123.08万股 拟减持股份",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "明华创新",
                        "减持",
                        "股份",
                        "1123.08万股"
                    ],
                    "sentiment_score": -0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "注意！甘李药业：股东明华创新计划减持不超过562万股公司股份 拟减持股份",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "明华创新",
                        "减持",
                        "股份",
                        "562万股"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "甘李药业(603087.SH)：明华创新及宽街博华拟合计减持不超1123.08万股 拟减持股份",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "明华创新",
                        "宽街博华",
                        "减持",
                        "股份",
                        "1123.08万股"
                    ],
                    "sentiment_score": -0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "甘李药业：明华创新等股东计划合计减持不超2%股份 拟减持股份",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "明华创新",
                        "股东",
                        "减持",
                        "股份",
                        "2%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "甘李药业：股东明华创新、宽街博华拟减持不超2% 拟减持股份",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "明华创新",
                        "宽街博华",
                        "减持",
                        "股份",
                        "2%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}